HighTide Therapeutics Inc

On the eve of the BIO International Convention 2026, the BIOSeedin Summer Innovation Partnering Summit in San Diego showcased China's differentiated innovative assets, drawing over 350 registrants and more than 200 on-site attendees from over 30 countries and regions. The summit, hosted by bioSeedin with strategic partners Thermo Fisher Scientific and ACROBiosystems, featured two sessions: one on early-stage strategy and innovation, where panelists emphasized that multinational corporations now view China as a core innovation fountain, and another on late-stage global ecosystems, highlighting that China and AI are permanent structural forces in the industry. Roadshow presentations were delivered by companies including Antengene, GeneScience Pharmaceutical, Salsola Therapeutics, HighTide Therapeutics, and others. The bioSeedin 1on1 Partnering System facilitated nearly 200 face-to-face meetings, reflecting strong interest in cross-border licensing and collaboration.